Sunil Abhyankar, MD

I completed my medical school from the University of Bombay followed by residency and specialized training in Pediatrics and Pediatric Hematology and Oncology from Wadia Hospital, University of Bombay and then subsequently at Downstate Medical Center in NYC. I then had the opportunity to be at the Dana Farber Cancer Institute in Boston, in BMT and focused on basic research in graft versus host disease. I have been involved with blood and marrow transplantation since 1990 and with cellular therapies from early 2000s. I currently am part of the Cellular Therapeutics team at the University of Kansas Cancer Center and oversee the cell processing lab and apheresis and also serve as the Director of the Midwest Stem cell therapy Center which has a GMP lab..

My research interests are in acute and chronic graft versus host disease, allogeneic transplant for malignant and non-malignant hematological disorders, infectious complications post BMT, Chimeric antigen receptor T and NK cell therapies and the use of mesenchymal and induced pluripotent cells in tissue regeneration.

131I-Apamistamab Improves Outcomes in Patients 65 Years and Older with Relapsed or Refractory AML

A multi-institutional study of extracorporeal photoimmune therapy (ECP) with UVADEX for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation (AHCT)

Autoimmune Hemolytic Anemia in children with AIDS

A Multi-Center, Phase III, Randomized Trial of Reduced Intensity Conditioning (RIC) and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow for Patients with Hematologic Malignancies